• Customer portal
logo logo
  • Medical Imaging
    • Medical Imaging
    • Our products
    • Ultrasound
    • Radiography
    • MRI
    • Mammography
    • Veterinary
  • Pathology
    • Digital Pathology
    • INIFY® Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
    • Publications
    • Sign Up
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • News
    • News
    • Sign up to INIFY newsletter
    • Events
    • In the media
    • Media kit
  • Investors
    • Investor news
    • Webcast
    • Podcast
    • Financial calendar
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
    • Media kit
  • Company
    • About ContextVision
    • Management
    • Board of directors
    • Career
    • ContextVision quality policy
  • Contact
    • Sales Digital Pathology
    • Sales OEM Medical Imaging
    • Customer Support
    • Headquarters
    • Investor relations & Media
    • Digital Pathology
    • OEM Medical Imaging
  • HEJ!
    • Research & Development
    • Artificial intelligence
    • The GOP technology
logo logo
  • Medical Imaging
  • Our products
  • Ultrasound
  • Radiography
  • Magnetic Resonance Imaging
  • Mammography
  • Veterinary
  • Pathology
    • Digital Pathology
    • INIFY® Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
    • Publications
    • Sign up
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • News
    • Latest news
    • Latest events
    • In the media
    • Media kit
  • Investors
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
    • Media kit
  • Company
    • About
    • Management
    • Board of Directors
    • Career
    • ContextVision quality policy
  • Contact
  • Customer Portal
INTERVIEW WITH FILIPPO FRAGGETTA

Diagnosing Cancer With Confidence

How bringing AI into the laboratory workflow can benefit both pathologist and patient

The Pathologist (11/10/2020)
Please visit https://thepathologist.com/inside-the-lab/diagnosing-cancer-with-confidence

  • ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world.

    Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.

    ContextVision is now entering the fast-growing digital pathology market. We are re-investing significantly in our product portfolio of decision support tools and we are dedicated to becoming a leading resource for pathologists to radically develop cancer diagnosis and improve patient care.

    The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.

© ContextVision AB (publ)